ClinicalTrials.Veeva

Menu
A

AI Centrum Medyczne | Poznan, Poland

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Filgotinib
Mirikizumab
Secukinumab
Lanraplenib
PF-06651600
Andecaliximab
MSB11456
TOFACITINIB
Ixekizumab
BMS-986165

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 12 total trials

A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis (OLINGUITO)

This study is comparing 200 milligrams (mg) of filgotinib a day with a placebo to see if filgotinib helps to treat Axial Spondyloarthritis (axSpA) an...

Active, not recruiting
Axial Spondyloarthritis
Drug: Placebo
Drug: Filgotinib

The purpose of this study is to evaluate the clinical efficacy and safety of nipocalimab in participants with moderate to severe Sjogren's disease (S...

Enrolling
Sjogrens Syndrome
Drug: Placebo
Drug: Standard of care treatment

Trial sponsors

A
Gilead Sciences logo
Janssen (J&J Innovative Medicine) logo
Lilly logo
Bristol-Myers Squibb (BMS) logo
Fresenius Kabi logo
M
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems